Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review.
about
Pioglitazone for type 2 diabetes mellitusInsulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic DisordersCardiovascular safety of anti-diabetic drugsTherapeutic Use of Metformin in Prediabetes and Diabetes PreventionAvoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetesGeneral aspects of muscle glucose uptakeCellular and molecular mechanisms of metformin: an overviewGut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studiesClinical utility of metabolic syndrome severity scores: considerations for practitioners.Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure?Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin.Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes.Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.[Caloric restriction in primates: how efficient as an anti-aging approach?].Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetesSingle phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes.Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathwaysMetformin-clinical pharmacology in PCOs.Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy statusDifferential effects of krill oil and fish oil on the hepatic transcriptome in miceThe double trouble of metabolic diseases: the diabetes-cancer link.Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.Advances in the treatment of nonalcoholic fatty liver disease.Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice.Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier.The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant ratsGlucose-lowering therapy in type 2 diabetes. New hope after the EMPA-REG outcome trialMetformin pathways: pharmacokinetics and pharmacodynamicsThe effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial.Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusThiazolidinedione derivatives in diabetes and cardiovascular disease: an update.Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.The metabolism of proline as microenvironmental stress substrate.Hepatic function and the cardiometabolic syndrome.Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetesInhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs
P2860
Q24244321-EAED6703-7D3F-409A-87F7-222A653A3820Q26740443-824A9C3E-0E59-4C3E-AB88-319A29708225Q26741082-12D2DE45-52ED-44A1-9720-21C6D978BCD0Q26822066-BF3DC8B0-B3C5-4487-947D-DAE58EEA29D6Q26827955-C6E50F01-23CC-40C5-B543-1289C23893D6Q26991925-365F2368-B6AA-4DA7-B9C3-8BB44E3371EAQ27013561-8BE5C14C-6F42-4DF3-9151-890739BD45C3Q28541879-37C7028C-4BFA-450F-B38C-E11FFE28B156Q30253051-08E564AF-E201-4597-A8B8-9E235D1438CCQ33825485-FD18081C-77A2-461B-A0BD-2699478F8DD5Q33857891-916177DD-DDD5-4CC3-8950-39F6F1A307AFQ34036950-981BFFBD-A975-47E3-B27E-3054B6A82BEDQ34113354-0AF1350B-117D-483F-9990-F88D668BC187Q34315432-E580D003-1013-446F-B0D0-8869BA473E01Q34442391-CDE9E44B-F69B-49EB-BE7E-4B54DB387B94Q34537051-7BEC32DD-5C7C-4120-ADE8-0D3879D8BD5CQ34606070-DD715E37-AF65-40CE-800B-5C863135D571Q34657137-A6130779-7BD4-4EAC-8F48-E357B09C0204Q35111555-357138E6-448E-4435-8E29-93A5171FDD06Q35275058-A17AC726-2D41-4355-93A6-ECF65893DCF2Q35349627-4542686C-9E64-4427-AE8F-27BB62530370Q35534198-A97589B6-E8ED-4E11-8345-94A6CCFFF7E5Q35711254-96B3E0BE-1565-4CE7-A20B-7CFD6FCD3209Q36058422-DE2112DA-754C-4B51-9AC3-2DF4F3D73CB1Q36084615-75192A84-D812-4885-83F4-CB306C927DD4Q36329908-285D0B60-A0FD-477D-BC95-4733B4E7C9CEQ36447454-07CD449A-2162-4B51-99A1-A8A088305E32Q36747796-6EA3059B-D2B5-4BB4-B276-4016C18FDE4FQ36811716-AE05ECC7-92CA-4042-811F-6065424F7266Q36820255-8BE7CCF0-B656-4181-8414-D6D68FA6FF0FQ36836472-2F2767DE-37A1-45E6-926E-5188AC479946Q37078178-E26E939F-7E2B-4592-99CB-B30AE0DFF9CBQ37141727-EB8A3E36-BFC4-486C-BC1B-4D4D4407E003Q37142138-0A244417-ACD1-466E-BFEE-DB273C8C3967Q37193773-DD427972-7BBD-4576-9CC6-7389E8220DA3Q37195539-E6FA26FA-9E6D-4259-BE8C-D49804B3974BQ37216401-BA31DDC5-02C0-4D32-8B3D-3BEB619DA3ABQ37232122-F068908E-A88B-4190-BBC2-DAFA16BE05D1Q37240102-95BB7CA8-C319-41B8-A273-2D0E8207B1A2Q37290387-A2AECF84-D2A9-48E5-98F0-2D9DCB98EE0C
P2860
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Effects of metformin and thiaz ...... diabetes: a systematic review.
@ast
Effects of metformin and thiaz ...... diabetes: a systematic review.
@en
type
label
Effects of metformin and thiaz ...... diabetes: a systematic review.
@ast
Effects of metformin and thiaz ...... diabetes: a systematic review.
@en
prefLabel
Effects of metformin and thiaz ...... diabetes: a systematic review.
@ast
Effects of metformin and thiaz ...... diabetes: a systematic review.
@en
P921
P1433
P1476
Effects of metformin and thiaz ...... diabetes: a systematic review.
@en
P2093
Ferrannini E
P2888
P304
P356
10.1007/S00125-006-0141-7
P577
2006-02-14T00:00:00Z